DaVita HealthCare Partners Inc (DVA)
Return on total capital
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | 2,090,480 | 1,602,780 | 1,339,060 | 1,797,370 | 1,694,640 |
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 121,122 | 1,056,100 | 712,326 | 755,508 | 1,383,570 |
| Return on total capital | 1,725.93% | 151.76% | 187.98% | 237.90% | 122.48% |
December 31, 2024 calculation
Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $2,090,480K ÷ ($—K + $121,122K)
= 1,725.93%
DaVita HealthCare Partners Inc's return on total capital has shown a significant increase over the period under review. The data indicates a strong performance, with the return on total capital standing at 122.48% as of December 31, 2020, and steadily increasing to 237.90% by December 31, 2021. Despite a slight decrease to 187.98% by December 31, 2022, the company maintained a robust performance, with a return on total capital of 151.76% by December 31, 2023.
The most notable observation is the substantial surge in the return on total capital to 1,725.93% as of December 31, 2024, signaling an exceptional performance that year. This exceptional performance in 2024 may be attributed to various factors such as improved operational efficiency, effective capital allocation strategies, or potentially extraordinary gains or events impacting the financial results.
Overall, DaVita HealthCare Partners Inc's return on total capital demonstrates a strong financial performance and efficient utilization of capital resources, especially highlighted by the remarkable performance in 2024.
Peer comparison
Dec 31, 2024